Diane Jorkasky - 27 Jun 2022 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Kent A. Tapper, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
27 Jun 2022
Net transactions value
-$151,472
Form type
4
Filing time
28 Jun 2022, 16:05:40 UTC
Previous filing
01 Oct 2021
Next filing
30 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Options Exercise $55,472 +17,610 $3.15 17,610 27 Jun 2022 Direct
transaction ALT Common Stock, par value $0.0001 Sale $206,944 -17,610 -100% $11.75 0 27 Jun 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Options Exercise $0 -17,610 -44% $0.000000 22,390 27 Jun 2022 Common Stock, par value $0.0001 40,000 $3.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.88, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney